Eurofins

OverviewSuggest Edit

Eurofins Scientific is a life sciences company providing laboratory testing services. It offers food, environmental, pharmaceutical, and cosmetic product testing, as well as agroscience contract research organization (CRO) services. The company also provides testing and laboratory services for genomics, discovery pharmacology, forensics, contract development and manufacturing organization (CDMO), advanced material sciences, etc.
TypePublic
Founded1987
HQLuxembourg, LU
Websiteeurofins.com
Employee Ratings3.4
Overall CultureB-

Latest Updates

Employees (est.) (Apr 2022)57,992
Job Openings5,897
Revenue (FY, 2020)€5.4 B(+20%)
Share Price (May 2022)€81.2(-1%)
Cybersecurity ratingDMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Eurofins

Gilles G. Martin

Gilles G. Martin

Founder, Chairman & CEO
Christian Wurst

Christian Wurst

Chief Operating Officer, Food & Environment Testing
Mathilde Latreille

Mathilde Latreille

Head of Clinical Trials Early Development.
Yves-Loïc Martin

Yves-Loïc Martin

Executive Director
Valérie Hanote

Valérie Hanote

Executive Director
Laurent Lebras

Laurent Lebras

Group Finance & Administration Director
Show more

Eurofins Office Locations

Eurofins has offices in Luxembourg, Alachua, Arvada, Austin and in 608 other locations
Luxembourg, LU (HQ)
23 Val Fleuri
Luxembourg, LU
10a Rue Henri M. Schnadt
Suzhou, CN
Huqiu District
Aix-en-Provence, FR
105 Avenue de Bredasque
Aix-en-Provence, FR
1bis Rue Aude
Aix-en-Provence, FR
210 Avenue du Grand Vallat
Show all (786)

Eurofins Financials and Metrics

Eurofins Revenue

Embed Graph
View revenue for all periods
Eurofins's revenue was reported to be €5.44 b in FY, 2020 which is a 19.2% increase from the previous period.
EUR

Revenue (H1, 2021)

3.3b

Net income (H1, 2021)

415.9m

EBITDA (H1, 2021)

989.1m

EBIT (H1, 2021)

724.6m

Market capitalization (12-May-2022)

15.6b

Closing stock price (12-May-2022)

81.2

Cash (30-Jun-2021)

639.9m

EV

17.6b
Eurofins's current market capitalization is €15.6 b.
Annual
EURFY, 2018FY, 2019FY, 2020

Revenue

3.8b4.6b5.4b

Revenue growth, %

27%21%19%

Cost of goods sold

1.3b1.5b1.7b

Gross profit

2.4b3.1b3.7b
Half Year
EURH1, 2019H1, 2020H1, 2021

Revenue

2.2b2.3b3.3b

Depreciation and amortization

182.2m199.7m204.4m

EBITDA

370.9m458.6m989.1m

EBITDA margin, %

17%20%30%
Annual
EURFY, 2018FY, 2019FY, 2020

Cash

506.2m297.0m912.4m

Accounts Receivable

864.9m853.8m993.4m

Prepaid Expenses

42.7m42.5m59.6m

Inventories

66.4m79.3m157.0m
Half Year
EURH1, 2019H1, 2020H1, 2021

Cash

304.6m615.4m639.9m

Accounts Receivable

913.7m978.3m

Prepaid Expenses

198.4m

Inventories

74.4m123.9m169.1m
Annual
EURFY, 2018FY, 2019FY, 2020

Net Income

289.8m271.5m694.4m

Depreciation and Amortization

223.7m395.9m426.0m

Inventories

(14.6m)(12.9m)(77.7m)

Accounts Payable

71.1m36.8m132.2m
Half Year
EURH1, 2019H1, 2020H1, 2021

Net Income

88.1m150.6m578.8m

Depreciation and Amortization

182.2m199.7m204.4m

Cash From Operating Activities

232.0m445.0m848.5m

Purchases of PP&E

(141.0m)(113.0m)(200.1m)
EURFY, 2018

Revenue/Employee

106.5k

Debt/Equity

1.2 x

Debt/Assets

0.4 x

Financial Leverage

2.6 x
Show all financial metrics

Eurofins Operating Metrics

FY, 2017FY, 2018FY, 2019FY, 2020

Business Sites

1.3 k1.4 k1.4 k

Countries

44475050

Facility Space, sq. m

1.25 m1.35 m1.4 m

Laboratories

400800800800

Eurofins Acquisitions / Subsidiaries

Company NameDateDeal Size
Lab SolutionJuly 11, 2019
Transplant Genomics Inc.June 25, 2019
Chemtest LimitedApril 11, 2019
EnvironeX GroupOctober 31, 2018
TestAmerica LaboratoriesOctober 31, 2018
Laboratoire DermscanOctober 29, 2018
Clinical Research LaboratoriesSeptember 04, 2018
Eurofins Nanolab TechnologiesAugust 02, 2018
Covance Food SolutionsAugust 01, 2018
Laboratorios EcosurJuly 27, 2018
Show more

Eurofins Revenue Breakdown

Embed Graph

Eurofins revenue breakdown by business segment: 5.9% from Study-Based Business, 88.0% from Sample-Based usiness and 6.1% from Other

Eurofins revenue breakdown by geographic segment: 7.5% from Rest of the World, 57.8% from Europe and 34.7% from North America

Human Capital Metrics

Embed Graph

Eurofins Cybersecurity Score

Cybersecurity ratingPremium dataset

D

69/100

SecurityScorecard logo

Eurofins Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

50-59

out of 100

CSRHub logo

Eurofins Online and Social Media Presence

Embed Graph

Eurofins Company Culture

  • Overall Culture

    B-

    69/100

  • CEO Rating

    B-

    70/100

  • Compensation

    C-

    60/100

  • Diversity

    A+

    84/100

Learn more on Comparably

Eurofins News and Updates

Eurofins Viracor and Cornell University Sign Exclusive Licensing Agreement to Expand Access to Ground-Breaking Technologies for Assessing Organ and Tissue Damage in Transplant and COVID-19 Patients

Blood and urine-based cell-free DNA detection methods will provide healthcare practitioners with highly accurate, non-invasive tools to identify and monitor for infection, rejection, and severity of organ damage in transplant and COVID-19 patients LEE'S SUMMIT, Mo., March 17, 2022...

Europe Markets: COVID-19 testing demand sends Eurofins into top French stock market index

Laboratory testing services group Eurofins Scientific is set to join France's top stock market index, buoyed by demand for COVID-19 testing.

Covid Test Maker Eurofins To Replace Atos in France’s CAC 40

Covid Test Maker Eurofins To Replace Atos in France’s CAC 40

Eurofins DQCI partners with Southeast Milk at Florida site

Dairy laboratory service company Eurofins DQCI is partnering with US dairy cooperative Southeast Milk, Inc. to assume operational responsibility of the Belleview, Florida site.Dairy laboratory service company Eurofins DQCI is partnering with US dairy cooperative Southeast Milk, Inc. to assume operat…

Fusion Antibodies teams up with Eurofins Discovery to provide antibody development services

StockMarketWire.com - Antibody engineering and supplier Fusion Antibodies said it had entered into a commercial collaboration agreement with Eurofins Discovery, a provider if products and services to the drug discovery industry.

Eurofins Expands Its Network of COVID-19 Testing Centers, Including Airports, Ports, Train Stations and Drive-Through Testing Centers, to Enable Convenient and Safe International Travel

As international travel for leisure and business continues to gather momentum, easy access to reliable and cost-effective testing is paramount to ensure safe and hassle-free travel experiences. Alongside further vaccination levels, wide-spread testing for SARS-CoV-2 (COVID-19), and sequencing of pos…
Show more

Eurofins Frequently Asked Questions

  • When was Eurofins founded?

    Eurofins was founded in 1987.

  • Who are Eurofins key executives?

    Eurofins's key executives are Gilles G. Martin, Christian Wurst and Mathilde Latreille.

  • How many employees does Eurofins have?

    Eurofins has 57,992 employees.

  • What is Eurofins revenue?

    Latest Eurofins annual revenue is €5.4 b.

  • What is Eurofins revenue per employee?

    Latest Eurofins revenue per employee is €93.8 k.

  • Who are Eurofins competitors?

    Competitors of Eurofins include Catalent, Labcorp Drug Development and Charles River Laboratories.

  • Where is Eurofins headquarters?

    Eurofins headquarters is located at 23 Val Fleuri, Luxembourg.

  • Where are Eurofins offices?

    Eurofins has offices in Luxembourg, Alachua, Arvada, Austin and in 608 other locations.

  • How many offices does Eurofins have?

    Eurofins has 786 offices.